Brochure | December 5, 2025

Elosity: Next-Generation RTSM, Built To Move At The Speed Of Your Trial

GettyImages-1358835459-computer-gear-digital-hands

Meet Elosity, Endpoint Clinical’s fifth-generation Randomization and Trial Supply Management (RTSM) platform, purpose-built to accelerate study startup, streamline collaboration, and simplify even the most complex clinical trial designs.

Leveraging over 15 years of operational expertise and modern cloud architecture, Elosity delivers unmatched flexibility and adaptability without compromising quality. Engineered from lessons learned across more than 2,000 studies spanning every phase, region, and therapeutic area, the platform supports rapid study builds, seamless mid-study adjustments, and global delivery with a follow-the-sun support model. Automated workflows and intuitive design reduce operational risk, improve compliance, and enhance efficiency, allowing study teams to focus on critical trial objectives rather than system limitations.

With its agile, user-centric approach, Elosity empowers sponsors, sites, and operational teams to manage clinical programs on their terms, providing a smarter, faster, and more reliable RTSM solution that keeps pace with the evolving demands of modern clinical research.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader